Sign in

Barclays PLC BARC.L

Price 493p
as of 2026-09-05
64/100
Constructive
Quality60
Growth63
Balance-sheet strength44
Valuation82
Momentum71
Income68

Composite 64/100; the shares have moved about 33% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Balance-sheet strength ranks 44/100 — a slight mark against it.

Case for

Valuation ranks 82/100 — a strong point in its favour. Momentum ranks 71/100 — a moderate point in its favour. Income ranks 68/100 — a moderate point in its favour.

Case against

Balance-sheet strength ranks 44/100 — a slight mark against it.

What the company does Barclays PLC is a diversified UK-headquartered bank offering retail, corporate, private, and investment banking, wealth and investment management, and credit card services across the UK, US, and international markets.

Key financials ROE 9.6%, ROA 0.4%, net margin 26.8%, revenue growth 3.9%, EPS growth 8.1%. Dividend yield 1.6% with a 17.8% payout ratio. Forward P/E 10.18 and PEG 0.48 signal valuation appeal.

Stock health Sideravia overall score 56.7 (average quality, attractively valued). Momentum: 12-month +32.70%, 3-month +14.27%, RSI(14) 42.00. Strength pillar 37.9/100 highlights balance-sheet concerns.

Price vs fair value The stock trades at a discount to both our fair-value estimate and analyst target. - Barclays cut Robinhood price targets alongside Goldman and Jefferies despite earnings beat (BeInCrypto). - Macro policy angst (Warsh Fed commentary) weighed on financials broadly (Bloomberg). - Sector peers UBS and Deutsche Bank reported Q2 gains, pressuring relative valuation (Zacks). - US GDP softening may temper near-term revenue momentum for US Consumer Bank (Bloomberg).

Looking forward Forward P/E of 10.18 and PEG of 0.48 suggest undemanding multiples, but growth (Growth pillar 48.6) remains modest. Execution in Private Bank and Investment Bank segments will be key to closing the valuation gap.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.